InspireMD (NSPR) Tops Q3 EPS by 2c

InspireMD (NYSE: NSPR) reported Q3 EPS of ($0.48), $0.02 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $632 thousand versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Middleby board approves spin-off of food processing unit Midera